Visfatin is upregulated in type-2 diabetic rats and targets renal cells

Young Sun Kang, Hye Kyoung Song, Mi Hwa Lee, Gang Jee Ko, Jee Young Han, Sang Youb Han, Kum Hyun Han, Hyoung Kyu Kim, Dae-Ryong Cha

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Visfatin (also known as pre-B cell colony-enhancing factor) is a newly discovered adipocytokine that is preferentially produced by visceral fat and regulated by cytokines promoting insulin resistance. Here we determined its renal synthesis and physiology in a genetic model of type 2 diabetes in rats. These rats had higher levels of visfatin synthesis in both glomeruli and tubulointerstitium compared to control rats. Plasma visfatin levels were significantly increased in the early stages of diabetic nephropathy and positively correlated with body weight, fasting plasma glucose, and microalbuminuria. Interestingly, visfatin synthesis was found to occur in podocytes and proximal tubular cells, as well as in adipocytes in vitro. Further, in both renal cells, visfatin synthesis was significantly increased by high glucose in the media but not by angiotensin II. Additionally, visfatin treatment induced rapid uptake of glucose and was associated with increased translocation of GLUT-1 to the cellular membrane of both renal cell types. Furthermore, visfatin induced tyrosine phosphorylation of the insulin receptor, activated downstream insulin signaling pathways such as Erk-1, Akt, and p38 MAPK, and markedly increased the levels of TGFΒ1, PAI-1, type I collagen, and MCP-1 in both renal cells. Thus, our results suggest that visfatin is produced by renal cells and has an important paracrine role in the pathogenesis of diabetic nephropathy.

Original languageEnglish
Pages (from-to)170-181
Number of pages12
JournalKidney International
Volume78
Issue number2
DOIs
Publication statusPublished - 2010 Jul 1

Fingerprint

Nicotinamide Phosphoribosyltransferase
Kidney
Diabetic Nephropathies
Glucose
Podocytes
Adipokines
Intra-Abdominal Fat
Genetic Models
Plasminogen Activator Inhibitor 1
Insulin Receptor
p38 Mitogen-Activated Protein Kinases
Collagen Type I
Adipocytes
Angiotensin II
Type 2 Diabetes Mellitus
Tyrosine
Insulin Resistance
Fasting
Body Weight
Phosphorylation

Keywords

  • diabetic nephropathy
  • glucose transporter-1
  • type-2 diabetic rats
  • visfatin

ASJC Scopus subject areas

  • Nephrology

Cite this

Visfatin is upregulated in type-2 diabetic rats and targets renal cells. / Kang, Young Sun; Song, Hye Kyoung; Lee, Mi Hwa; Ko, Gang Jee; Han, Jee Young; Han, Sang Youb; Han, Kum Hyun; Kim, Hyoung Kyu; Cha, Dae-Ryong.

In: Kidney International, Vol. 78, No. 2, 01.07.2010, p. 170-181.

Research output: Contribution to journalArticle

Kang, Young Sun ; Song, Hye Kyoung ; Lee, Mi Hwa ; Ko, Gang Jee ; Han, Jee Young ; Han, Sang Youb ; Han, Kum Hyun ; Kim, Hyoung Kyu ; Cha, Dae-Ryong. / Visfatin is upregulated in type-2 diabetic rats and targets renal cells. In: Kidney International. 2010 ; Vol. 78, No. 2. pp. 170-181.
@article{588c47208cb344e8ba03a13c0ad38446,
title = "Visfatin is upregulated in type-2 diabetic rats and targets renal cells",
abstract = "Visfatin (also known as pre-B cell colony-enhancing factor) is a newly discovered adipocytokine that is preferentially produced by visceral fat and regulated by cytokines promoting insulin resistance. Here we determined its renal synthesis and physiology in a genetic model of type 2 diabetes in rats. These rats had higher levels of visfatin synthesis in both glomeruli and tubulointerstitium compared to control rats. Plasma visfatin levels were significantly increased in the early stages of diabetic nephropathy and positively correlated with body weight, fasting plasma glucose, and microalbuminuria. Interestingly, visfatin synthesis was found to occur in podocytes and proximal tubular cells, as well as in adipocytes in vitro. Further, in both renal cells, visfatin synthesis was significantly increased by high glucose in the media but not by angiotensin II. Additionally, visfatin treatment induced rapid uptake of glucose and was associated with increased translocation of GLUT-1 to the cellular membrane of both renal cell types. Furthermore, visfatin induced tyrosine phosphorylation of the insulin receptor, activated downstream insulin signaling pathways such as Erk-1, Akt, and p38 MAPK, and markedly increased the levels of TGFΒ1, PAI-1, type I collagen, and MCP-1 in both renal cells. Thus, our results suggest that visfatin is produced by renal cells and has an important paracrine role in the pathogenesis of diabetic nephropathy.",
keywords = "diabetic nephropathy, glucose transporter-1, type-2 diabetic rats, visfatin",
author = "Kang, {Young Sun} and Song, {Hye Kyoung} and Lee, {Mi Hwa} and Ko, {Gang Jee} and Han, {Jee Young} and Han, {Sang Youb} and Han, {Kum Hyun} and Kim, {Hyoung Kyu} and Dae-Ryong Cha",
year = "2010",
month = "7",
day = "1",
doi = "10.1038/ki.2010.98",
language = "English",
volume = "78",
pages = "170--181",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Visfatin is upregulated in type-2 diabetic rats and targets renal cells

AU - Kang, Young Sun

AU - Song, Hye Kyoung

AU - Lee, Mi Hwa

AU - Ko, Gang Jee

AU - Han, Jee Young

AU - Han, Sang Youb

AU - Han, Kum Hyun

AU - Kim, Hyoung Kyu

AU - Cha, Dae-Ryong

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Visfatin (also known as pre-B cell colony-enhancing factor) is a newly discovered adipocytokine that is preferentially produced by visceral fat and regulated by cytokines promoting insulin resistance. Here we determined its renal synthesis and physiology in a genetic model of type 2 diabetes in rats. These rats had higher levels of visfatin synthesis in both glomeruli and tubulointerstitium compared to control rats. Plasma visfatin levels were significantly increased in the early stages of diabetic nephropathy and positively correlated with body weight, fasting plasma glucose, and microalbuminuria. Interestingly, visfatin synthesis was found to occur in podocytes and proximal tubular cells, as well as in adipocytes in vitro. Further, in both renal cells, visfatin synthesis was significantly increased by high glucose in the media but not by angiotensin II. Additionally, visfatin treatment induced rapid uptake of glucose and was associated with increased translocation of GLUT-1 to the cellular membrane of both renal cell types. Furthermore, visfatin induced tyrosine phosphorylation of the insulin receptor, activated downstream insulin signaling pathways such as Erk-1, Akt, and p38 MAPK, and markedly increased the levels of TGFΒ1, PAI-1, type I collagen, and MCP-1 in both renal cells. Thus, our results suggest that visfatin is produced by renal cells and has an important paracrine role in the pathogenesis of diabetic nephropathy.

AB - Visfatin (also known as pre-B cell colony-enhancing factor) is a newly discovered adipocytokine that is preferentially produced by visceral fat and regulated by cytokines promoting insulin resistance. Here we determined its renal synthesis and physiology in a genetic model of type 2 diabetes in rats. These rats had higher levels of visfatin synthesis in both glomeruli and tubulointerstitium compared to control rats. Plasma visfatin levels were significantly increased in the early stages of diabetic nephropathy and positively correlated with body weight, fasting plasma glucose, and microalbuminuria. Interestingly, visfatin synthesis was found to occur in podocytes and proximal tubular cells, as well as in adipocytes in vitro. Further, in both renal cells, visfatin synthesis was significantly increased by high glucose in the media but not by angiotensin II. Additionally, visfatin treatment induced rapid uptake of glucose and was associated with increased translocation of GLUT-1 to the cellular membrane of both renal cell types. Furthermore, visfatin induced tyrosine phosphorylation of the insulin receptor, activated downstream insulin signaling pathways such as Erk-1, Akt, and p38 MAPK, and markedly increased the levels of TGFΒ1, PAI-1, type I collagen, and MCP-1 in both renal cells. Thus, our results suggest that visfatin is produced by renal cells and has an important paracrine role in the pathogenesis of diabetic nephropathy.

KW - diabetic nephropathy

KW - glucose transporter-1

KW - type-2 diabetic rats

KW - visfatin

UR - http://www.scopus.com/inward/record.url?scp=77954230878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954230878&partnerID=8YFLogxK

U2 - 10.1038/ki.2010.98

DO - 10.1038/ki.2010.98

M3 - Article

C2 - 20375985

AN - SCOPUS:77954230878

VL - 78

SP - 170

EP - 181

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -